According to a new report by Polaris Market Research, the global immunotherapy drugs market was valued at USD 327.74 billion in 2025 and is projected to reach USD 1,152.03 billion by 2034, expanding at a CAGR of 15.0% over the forecast period. Growth is underpinned by rising cancer and autoimmune disease prevalence, expanding CAR-T and checkpoint-inhibitor pipelines, and...